TESTOSTERONE UNDECYLATE
Nsclc
Aminex Therapeutics, Inc.Small moleculePhase 1/2Active
CC
41/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 65/ 100
Competitive context
2 Active assets in the Nsclc cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Para-Toluenesulfonamide PTS International Inc. | Phase 3 | CCC |
Amxt1501 Aminex Therapeutics, Inc. | Phase 1/2 | CC |
Eflornithine Aminex Therapeutics, Inc. | Phase 1/2 | CC |
Same molecule, other indications
TESTOSTERONE UNDECYLATE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →